177 related articles for article (PubMed ID: 26402166)
21. Myelofibrosis in the myeloproliferative disorders.
Ellis JT; Peterson P
Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
[TBL] [Abstract][Full Text] [Related]
22. Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.
Ghanima W; Junker P; Hasselbalch HC; Boiocchi L; Geyer JT; Feng X; Gudbrandsdottir S; Orazi A; Bussel JB
Br J Haematol; 2011 Oct; 155(2):248-55. PubMed ID: 21902682
[TBL] [Abstract][Full Text] [Related]
23. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study.
Ahmed A; Powers MP; Youker KA; Rice L; Ewton A; Dunphy CH; Chang CC
Pathol Res Pract; 2009; 205(9):634-8. PubMed ID: 19446406
[TBL] [Abstract][Full Text] [Related]
24. Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical, and Therapeutic Implications.
Nazha A; Khoury JD; Rampal RK; Daver N
Oncologist; 2015 Oct; 20(10):1154-60. PubMed ID: 26304912
[TBL] [Abstract][Full Text] [Related]
25. [Secondary myelofibrosis and/or osteosclerosis. An assessment of 400 biopsies (author's transl)].
Hernández Nieto L; Muncunill J; Rozman C; Fabregues M; Feliú E; Grañena A; Montserrat-Costa E; Nomdedeu B
Sangre (Barc); 1978; 23(4):402-10. PubMed ID: 705562
[No Abstract] [Full Text] [Related]
26. Myelofibrosis progression grading based on type I and type III collagen and fibrillin 1 expression boosted by whole slide image analysis.
Szekely T; Wichmann B; Maros ME; Csizmadia A; Bodor C; Timar B; Krenacs T
Histopathology; 2023 Mar; 82(4):622-632. PubMed ID: 36416374
[TBL] [Abstract][Full Text] [Related]
27. [The value of the initial bone biopsy in chronic myeloproliferative syndromes. Review of 80 cases].
Ortuño F; Zuazu I; Bordes R; Brunet S; Puig J; Ayats R
Sangre (Barc); 1989 Apr; 34(2):117-25. PubMed ID: 2667169
[TBL] [Abstract][Full Text] [Related]
28. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres.
Kuter DJ; Bain B; Mufti G; Bagg A; Hasserjian RP
Br J Haematol; 2007 Nov; 139(3):351-62. PubMed ID: 17910625
[TBL] [Abstract][Full Text] [Related]
31. Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies.
Thiele J; Chen YS; Kvasnicka HM; Diehl V; Fischer R
Leuk Lymphoma; 1994 Jun; 14(1-2):163-9. PubMed ID: 7920225
[TBL] [Abstract][Full Text] [Related]
32. [Quantitative study of the medullar fibrosis in 84 cases of idiopathic myeloid splenomegaly (author's transl)].
Dumont J; d'Athis P; Atken N; Binet JL; Ripault J; Worhauer W; Bernard J
Pathol Biol (Paris); 1979 Apr; 27(4):221-6. PubMed ID: 379761
[TBL] [Abstract][Full Text] [Related]
33. Normal reticulin level in iliac bone marrow.
Beckman EN; Brown AW
Arch Pathol Lab Med; 1990 Dec; 114(12):1241-3. PubMed ID: 2252420
[TBL] [Abstract][Full Text] [Related]
34. A histomorphometric study of haematological disorders with respect to marrow fibrosis and osteosclerosis.
Poulsen LW; Melsen F; Bendix K
APMIS; 1998 Apr; 106(4):495-9. PubMed ID: 9637273
[TBL] [Abstract][Full Text] [Related]
35. [Myeloid leukemia with myelofibrosis (author's transl)].
Duhamel G; Gorin NC; Najaman A; André R
Nouv Rev Fr Hematol; 1975; 15(1):99-105. PubMed ID: 126427
[TBL] [Abstract][Full Text] [Related]
36. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
Tovar-Bobadilla JL; Ortiz-Hidalgo C
Gac Med Mex; 2016; 152(3):407-18. PubMed ID: 27335198
[TBL] [Abstract][Full Text] [Related]
37. A Diagnostic Impact of Serum Autotaxin Levels in Patients with Bone Marrow Fibrosis.
Nakazawa H; Kaiume H; Igarashi K; Yamazaki T; Umemura T; Asano N; Uehara T; Ishida F
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e117-e124. PubMed ID: 36567212
[TBL] [Abstract][Full Text] [Related]
38. Grading of marrow fibrosis in chronic myeloid leukemia--a comprehensive approach.
Rao S; Sen R; Singh S; Ghalaut PS; Arora BB
Indian J Pathol Microbiol; 2005 Jul; 48(3):341-4. PubMed ID: 16761746
[TBL] [Abstract][Full Text] [Related]
39. Follow-up study on bone marrow reticulin fibrosis in AML.
Thiele J; Grashof K; Fisher R
Anal Cell Pathol; 1991 Jul; 3(4):225-31. PubMed ID: 1883746
[TBL] [Abstract][Full Text] [Related]
40. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
Straetmans N; Ma DD; Nevell DF; Arthur C
Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
